A series of recently published large-scale and independent meta-analyses have confirmed Favipiravir to be effective against mild to moderate COVID-19.… Read more
The World’s Largest Meta-Analysis Using Real-World Favipiravir Data Demonstrates Significant Clinical Improvements and Promotes Enhanced Viral Clearance in Mild-to-Moderate COVID-19 Patients
